EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Comparative Efficacy of Meropenem Versus Meropenem Combined with Azithromycin in Treating Extensively Drug-Resistant Uncomplicated Typhoid Fever

Fawad Ahmad, Jamal Anwer, Hafiz Muhammad Usman Ali Ashraf Ahmad, Sajida Khalid

Journal of Gandhara Medical and Dental Science · 30.06.2026 · 13 (3) · 64-70

DOI: 10.37762/jgmds.13-3.905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gandhara Medical and Dental Science, online erschienen am 30.06.2026. Verfasst von Fawad Ahmad und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES To compare the effectiveness of treating children with meropenem monotherapy vs meropenem plus azithromycin for cases of unexplained typhoid fever that have developed resistance to other drugs. METHODOLOGY This study aimed to compare the clinical efficacy and safety of meropenem alone versus meropenem combined with azithromycin in treating pediatric patients with XDR uncomplicated typhoid fever in a randomised controlled trial (ClinicalTrials.gov Identifier: NCT07445282). Over 6 months, a randomised controlled trial was conducted at the Department of Pediatric Medicine at Sheikh Zayed Hospital in Rahim Yar Khan. Ninety children, aged six months to under five years, with blood-culture–confirmed XDR S. Typhi were included and randomly divided into two groups. Group A received meropenem IV (20–40 mg/kg every 8 hours), and Group B received meropenem and azithromycin by mouth (20 mg/kg/day). The main goal was the average time it took for the fever to go down. We used SPSS version 25.0 to analyse the data, setting the p-value to 0.05. RESULTSThe mean time to defervescence was significantly shorter in the combination group (5.4 ± 2.1 days) than in the meropenem group (6.5 ± 2.8 days; p = 0.02). In the combination group, 93.3% of patients saw clinical improvement, while in the monotherapy group, only 82.2% did (p = 0.04). The dual regimen significantly reduced the mean time to ovulation and the frequency of clinical alterations, without a significant increase in adverse events, compared with the monotherapy or the combination therapy in young children with severe drug-resistant (XDR) straightforward fever. CONCLUSION This study provides substantial evidence for optimising antibiotic therapy in pediatric XDR tachycardia by systematically assessing the clinical outcomes of two therapeutic regimens. The results are anticipated to enhance clinical practice, inform antibiotic stewardship initiatives, and support the global effort to mitigate antimicrobial resistance.

Zitieren

APA

Ahmad, F., Anwer, J., Ahmad, H. M. U. A. A., & Khalid, S. (2026). Comparative Efficacy of Meropenem Versus Meropenem Combined with Azithromycin in Treating Extensively Drug-Resistant Uncomplicated Typhoid Fever. Journal of Gandhara Medical and Dental Science, 13(3), 64-70. https://doi.org/10.37762/jgmds.13-3.905

Vancouver

Ahmad F, Anwer J, Ahmad HMUAA, Khalid S. Comparative Efficacy of Meropenem Versus Meropenem Combined with Azithromycin in Treating Extensively Drug-Resistant Uncomplicated Typhoid Fever. Journal of Gandhara Medical and Dental Science. 2026;13(3):64-70. doi:10.37762/jgmds.13-3.905

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Fawad and Anwer, Jamal and Ahmad, Hafiz Muhammad Usman Ali Ashraf and Khalid, Sajida},
  title = {Comparative Efficacy of Meropenem Versus Meropenem Combined with Azithromycin in Treating Extensively Drug-Resistant Uncomplicated Typhoid Fever},
  journal = {Journal of Gandhara Medical and Dental Science},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {64--70},
  doi = {10.37762/jgmds.13-3.905}
}
Kostenlos starten →